Portugal needs to perform 1.2 million cancer screenings per year
The director of the National Program for Oncological Diseases estimated on Thursday that more 1.2 million monitors for breast, cervical and colorectal cancer to cover more than 90% of the eligible population by 2025.
This is a proposed objective not European Program to Fight Cancer José Dinis will result before 2055 “taking the reference results obtained in 29, as well as the power to verify1 the entire Lisbon and Tagus Valley region in 20222”.
“No tracking do cervix cancerone is esteemed deficit of about 200 thousand invitations [para rastreio] per annum. Considering that it is an activity control exclusively focused on the family doctor and the stability of the Deficit between 2016 and 2019, it will be necessary to explore a number of successes in 2025″, said José Dinis online session for the presentation of the Results of the Baseline Oncological Screenings Population 2019 and 2020, without the scope of World Cancer Day.
no control do colon and rectal cancerIt’s budget a deficit of around 900 thousand invitations perno, with the director of the National Program for Oncological Diseases to consider that “is the only male in the population whose eligible population includes the program with the highest population and control per year“, while for breast cancer it will be necessary to carry out around 120 thousand calls per year.
Speaking to the Lusa agency, José Dinis said that this is “the challenge for Portugal, and for all European countries where each one follows at different speeds, for which the Europe will contribute funds to reinforce programs“, it is already foreseen not Recovery and Resilience Plan.
Scientists develop unique test capable of detecting women’s risk of developing four types of cancer
José Dinis said that countries should establish advertisers policies with policies to achieve the proposed objectives that will be subject to European monitoring and that in Portugal are already mandatory for the National Health Service, namely as they are mandatory for the National Health Service.
Brussels wants early detection of cancer in the EU and an end to inequalities in treatment
In the presentation of the Oncological Screening Results, José Dinis highlighted “the recovery” of breast cancer screening activityevidenced by the increase in the number of invitations and the number of women screened, recovering the upward pattern that I had been noticing since 2016.
“We analyzed the evolution of tracking 2019 and the 2021 regions in the five clear health activities of the year 20, which can be considered as a consequence of the pandemic, and in the North region it was still a lot due to administrative problems, solved”, he said.
stressed “the highlight of the activity in Lisbon and the Tagus” explain that the increase in the risk of cancer in the region should increase, which is expected to be concluded this year.
Regarding the tracking of uterine activity, also cancer has become the recovery of levels to 019 activity levels, pre-anodemic.
“It is important to highlight that the invitation to participate in this device is responsible for the intervention of the family doctor, meaning that those who do not attend the health unit are not invited”warned José Dinis.
There was also no championship cancer screening and retouching at 20 of activity out of 21, with levels of the invited population at similar to 20019.
“In the regional analysis of monitoring, it appears that the monitoring of monitoring and feedback is overwhelmingly implemented in the North Region”, said the director of the National Program for Oncological Diseases, defending that it is a priority to “solve the metrics”.
The Alentejo has resumed this tracking program, which had been stopped since 2019 and in the other regions does not match the levels obtained in 2019, he stressed.
Present in the initiative, a director general of health argued that population-based cancer monitors “will have to be reinforced, reinforced and accessible to the entire population” to comply with the European plan.
“We have a great challenge ahead of us, so it is important for everyone to collaborate so that Portugal, at the end of 2025, is once again an example for Europe as it already is in vaccine coverage against HPV, hepatitis B and against Covid -19”, pointed out Grace Freitas.
The Director-General of Health recorded that oncological diseases are the main cause of premature death, accounting for more than 100,000 potential years of life lost” and said that the number of years of life lost due to oncological diseases is “eight times more than the number that is attributed to infection by the virus”. human immunodeficiency virus (HIV)two and a half times more than the assigned risk alcohol consumption and one and a half times higher than that attributed to cardiovascular diseases“.